SE9803891D0 - Protein Variants - Google Patents

Protein Variants

Info

Publication number
SE9803891D0
SE9803891D0 SE9803891A SE9803891A SE9803891D0 SE 9803891 D0 SE9803891 D0 SE 9803891D0 SE 9803891 A SE9803891 A SE 9803891A SE 9803891 A SE9803891 A SE 9803891A SE 9803891 D0 SE9803891 D0 SE 9803891D0
Authority
SE
Sweden
Prior art keywords
alpha
human hif
essentially
domain
amino acids
Prior art date
Application number
SE9803891A
Other languages
English (en)
Swedish (sv)
Inventor
Anders Berkenstam
Lorenz Poellinger
Original Assignee
Pharmacia & Upjohn Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Ab filed Critical Pharmacia & Upjohn Ab
Priority to SE9803891A priority Critical patent/SE9803891D0/xx
Publication of SE9803891D0 publication Critical patent/SE9803891D0/xx
Priority to KR1020017005928A priority patent/KR100648761B1/ko
Priority to BR9915263-0A priority patent/BR9915263A/pt
Priority to JP2000582422A priority patent/JP2002530063A/ja
Priority to NZ511450A priority patent/NZ511450A/en
Priority to AU15931/00A priority patent/AU761594B2/en
Priority to EP99958594A priority patent/EP1141005B1/en
Priority to DE69937199T priority patent/DE69937199D1/de
Priority to AT99958594T priority patent/ATE374210T1/de
Priority to CA002350830A priority patent/CA2350830A1/en
Priority to PCT/SE1999/002053 priority patent/WO2000029437A1/en
Priority to CNB99814388XA priority patent/CN1330666C/zh
Priority to TR2001/01345T priority patent/TR200101345T2/xx
Priority to US09/438,833 priority patent/US6436654B1/en
Priority to ZA200103669A priority patent/ZA200103669B/en
Priority to HK02105080.8A priority patent/HK1043372B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Semiconductor Lasers (AREA)
  • Radar Systems Or Details Thereof (AREA)
  • Amplifiers (AREA)
  • Testing, Inspecting, Measuring Of Stereoscopic Televisions And Televisions (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
SE9803891A 1998-11-13 1998-11-13 Protein Variants SE9803891D0 (sv)

Priority Applications (16)

Application Number Priority Date Filing Date Title
SE9803891A SE9803891D0 (sv) 1998-11-13 1998-11-13 Protein Variants
TR2001/01345T TR200101345T2 (tr) 1998-11-13 1999-11-11 Hipoksiya'nın oluşturabildiği faktör 1alfa HIF-1alfa'nın değişik biçimleri için yöntemler.
EP99958594A EP1141005B1 (en) 1998-11-13 1999-11-11 Method for identifying hif-1alpha modulators
AT99958594T ATE374210T1 (de) 1998-11-13 1999-11-11 Verfahren zur identifikation von modulatoren von hif-1-alpha
JP2000582422A JP2002530063A (ja) 1998-11-13 1999-11-11 低酸素誘導性因子１α（ＨＩＦ−１α）変異体およびＨＩＦ−１α調整因子の同定法
NZ511450A NZ511450A (en) 1998-11-13 1999-11-11 Method of identifying compounds that modulate the function of the human hypoxia-inducible factor 1-alpha (HIF-1alpha) functional domain
AU15931/00A AU761594B2 (en) 1998-11-13 1999-11-11 Hypoxia-inducible factor 1alpha HIF-1alpha variants and methods for identifying HIF-1alpha modulators
KR1020017005928A KR100648761B1 (ko) 1998-11-13 1999-11-11 저산소증-유도성 인자 1α ＨＩＦ-1α 변이체 및ＨＩＦ-1α 조절제의 동정 방법
DE69937199T DE69937199D1 (de) 1998-11-13 1999-11-11 Verfahren zur identifikation von modulatoren von hif-1-alpha
BR9915263-0A BR9915263A (pt) 1998-11-13 1999-11-11 Variantes do fator hif-1 "alfa" que induz à hipoxiahumana e métodos para identificação dosmoduladores de hif-1 "alfa"
CA002350830A CA2350830A1 (en) 1998-11-13 1999-11-11 Hypoxia-inducible factor 1.alpha. hif-1.alpha. variants and methods for identifying hif-1.alpha. modulators
PCT/SE1999/002053 WO2000029437A1 (en) 1998-11-13 1999-11-11 HYPOXIA-INDUCIBLE FACTOR 1α HIF-1α VARIANTS AND METHODS FOR IDENTIFYING HIF-1α MODULATORS
CNB99814388XA CN1330666C (zh) 1998-11-13 1999-11-11 低氧－诱导因子1αHIF－1α变体和鉴定HIF－1α调节剂的方法
US09/438,833 US6436654B1 (en) 1998-11-13 1999-11-12 Methods for identifying compounds that modulate HIF-1α
ZA200103669A ZA200103669B (en) 1998-11-13 2001-05-07 Hypoxia-inducible factor 1a HIF-1α variants and methods for identifying HIF-1α modulators.
HK02105080.8A HK1043372B (zh) 1998-11-13 2002-07-09 低氧-誘導因子1αHIF-1α變體和鑒定HIF-1α調節劑的方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9803891A SE9803891D0 (sv) 1998-11-13 1998-11-13 Protein Variants

Publications (1)

Publication Number Publication Date
SE9803891D0 true SE9803891D0 (sv) 1998-11-13

Family

ID=20413284

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9803891A SE9803891D0 (sv) 1998-11-13 1998-11-13 Protein Variants

Country Status (15)

Country Link
EP (1) EP1141005B1 (xx)
JP (1) JP2002530063A (xx)
KR (1) KR100648761B1 (xx)
CN (1) CN1330666C (xx)
AT (1) ATE374210T1 (xx)
AU (1) AU761594B2 (xx)
BR (1) BR9915263A (xx)
CA (1) CA2350830A1 (xx)
DE (1) DE69937199D1 (xx)
HK (1) HK1043372B (xx)
NZ (1) NZ511450A (xx)
SE (1) SE9803891D0 (xx)
TR (1) TR200101345T2 (xx)
WO (1) WO2000029437A1 (xx)
ZA (1) ZA200103669B (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9911047D0 (en) 1999-05-12 1999-07-14 Isis Innovation Assay method and means
ES2299427T3 (es) * 1999-06-04 2008-06-01 Dana-Farber Cancer Institute, Inc. Identificacion de compuestos que modifiquen respuestas transcripcionales a la hipoxia.
EP1348033A2 (en) * 2000-05-26 2003-10-01 Board of Trustees of the University of Illinois Reagents and methods for identifying and modulating expression of genes regulated by retinoids
CN1835969A (zh) * 2000-08-07 2006-09-20 血管基因瑞典有限公司 冯希普尔－林道肿瘤抑制蛋白对低氧诱导因子－1的条件调节机制
US20030045830A1 (en) * 2001-04-17 2003-03-06 De Bizemont Therese Gene therapy with chimeric oligonucleotides delivered by a method comprising a step of iontophoresis
WO2002094862A2 (en) 2001-05-23 2002-11-28 Angiogene Inc. Hypoxia inducible factors and uses thereof for inducing angiogenesis and improving muscular functions
EP1842856A3 (en) * 2001-05-23 2007-12-12 Angiogene Inc. Hypoxia inducing factors and uses thereof for inducing angiogenesis and improving muscular functions
AU2003201798A1 (en) * 2002-01-11 2003-09-02 Angio Genetics Sweden Ab Hif-1 alpha proteins mutated in the c-terminal transactivation domain
CN100366747C (zh) * 2005-03-08 2008-02-06 上海第二医科大学附属仁济医院 低氧诱导因子小干扰rna质粒
CN100418574C (zh) * 2005-10-26 2008-09-17 王成球 一类封闭人类HIF-1α基因和调控网络中下游相关基因的染色质肽
CN102127161B (zh) * 2010-12-16 2013-03-27 何明忠 抗肿瘤多肽及其用途
CN106366173A (zh) * 2015-07-24 2017-02-01 北京京爱康科技有限公司 一种通过结合低氧反应元件控制缺氧反应基因表达的染色质肽

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5882914A (en) * 1995-06-06 1999-03-16 The Johns Hopkins University School Of Medicine Nucleic acids encoding the hypoxia inducible factor-1

Also Published As

Publication number Publication date
HK1043372B (zh) 2008-05-09
CA2350830A1 (en) 2000-05-25
BR9915263A (pt) 2001-10-30
JP2002530063A (ja) 2002-09-17
NZ511450A (en) 2003-08-29
AU1593100A (en) 2000-06-05
HK1043372A1 (en) 2002-09-13
CN1330666C (zh) 2007-08-08
CN1330663A (zh) 2002-01-09
TR200101345T2 (tr) 2001-10-22
EP1141005A1 (en) 2001-10-10
ZA200103669B (en) 2002-05-07
EP1141005B1 (en) 2007-09-26
AU761594B2 (en) 2003-06-05
KR100648761B1 (ko) 2006-11-23
WO2000029437A1 (en) 2000-05-25
DE69937199D1 (de) 2007-11-08
KR20010080411A (ko) 2001-08-22
ATE374210T1 (de) 2007-10-15

Similar Documents

Publication Publication Date Title
ATE352617T1 (de) Lösliche polypeptidfraktionen des lag-3-proteins; verfahren zur herstellung; therapeutische zusamensetzung; antiidiotypischer antikörper
SE9803891D0 (sv) Protein Variants
HK1027112A1 (en) Survivin, a protein that inhibits cellular apoptosis, and its modulation
DE60023936D1 (de) Methoden zur verwendung von randomisierten zinkfingerprotein-bibliotheken zur identifizierung von genfunktionen
BR9912545A (pt) ácidos nucleicos codificando um receptorcopulado a proteìna g envolvido em transduçãosensorial
ATE382148T1 (de) Antikörper für apoptosemarker und anwendungsverfahren
ATE278710T1 (de) Antimikrobiell wirksame peptide
DE69534252D1 (de) Enzyme zur spaltung der verankerungsregion von oberflächenproteinen aus gram-positiven bakterien
DE3587875D1 (de) Rekombinantverfahren zur herstellung von serinproteaseinhibitoren, sowie dns-sequenzen dazu.
ATE292801T1 (de) Verfahren zum screening von inhibitoren von asp2
ATE301714T1 (de) Insulinartigen wachstumsfaktor bindendes protein -3 variante
DE69628449D1 (de) Verfahren zur identifizierung unbekannter allele
DE69720738D1 (de) Zusammensetzung und verfahren zur verhinderung von proteinablagerung auf kontaktlinsen
BR9510067A (pt) Peptídio capaz de interagir com o domínio sh3 da proteína gap anticorpo ou fragmento de anticorpo dirigido contra um polipeptídeo sequência nucleotídica codificando para um polipeptídio ácido nucléico anti-sentido capaz de inibir ao menos parcialmente a produção de polipeptídeos sua utilização composição farmacêutica e utilização de um anticorpo ou fragmento de anticorpo
KR930023469A (ko) 베타 아밀로이드 전구 단백질 프로세싱 효소의 검출 방법
TR200002101T2 (tr) Dondurulmuş gıda ürünü.
ATE190318T1 (de) Pcna bindende substanz
ATE432287T1 (de) Peptidfragmente mit den zelltod verhindernder aktivität
ATE405649T1 (de) Hemmstoff zur diagnose und behandlung von haemophilia a patienten
AR007279A1 (es) Composicion para la tincion y tonalizacion de cabellos
ATE121421T1 (de) Hemmung von migration von zellen mit hilfe von synthetischen peptiden.
ATE393224T1 (de) Nukleinsäuresequenzen von hyperplasien und tumoren der schilddrüse
DE60221698D1 (de) Nukleares protein "shoca" - eine komponente des wnt signaltransduktionsweges
Katayama et al. Specific cleavage of reduced and S-carboxamidomethylated neurophysin II by the collagenase of Clostridium histolyticum
DE69813836D1 (de) Oligonukleotide zur identifizierung von amidierten polypeptid-hormonvorläufern